Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$671 Mln
Revenue (TTM)
$221 Mln
Net Profit (TTM)
$0 Mln
ROE
-22.4 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
107.7
Industry P/E
61.46
EV/EBITDA
252.6
Div. Yield
0 %
Debt to Equity
-2.9
Book Value
$--
EPS
$-0.3
Face value
--
Shares outstanding
45,447,600
CFO
$-61.47 Mln
EBITDA
$-153.39 Mln
Net Profit
$-195.07 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
LifeMD (LFMD)
| 188.9 | 24.3 | 155.4 | 105.5 | 85.8 | 54.2 | 43.0 |
|
BSE Sensex*
| 4.9 | 0.4 | 6.7 | 6.3 | 16.2 | 18.3 | 11.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
LifeMD (LFMD)
| -40.0 | 327.3 | -49.9 | -40.7 | 1,035.7 | -17.9 | -58.6 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
LifeMD (LFMD)
|
14.3 | 670.8 | 220.9 | -11.5 | -3.4 | -- | -- | 107.7 |
| 13.4 | 9,247.0 | 6,685.2 | 715.6 | 16.4 | 12.3 | 13 | 1.5 | |
| 250.1 | 6,628.2 | 2,541.1 | -2,228.1 | -106.3 | -31.5 | -- | 1.0 | |
| 235.5 | 6,430.5 | 2,541.1 | -2,228.1 | -106.3 | -31.5 | -- | 0.9 | |
| 96.8 | 5,722.6 | 404.5 | -123.7 | -26.1 | -17.3 | -- | 7.5 | |
| 57.8 | 7,834.4 | 2,510.8 | 185.6 | 8.8 | 4.5 | 43.2 | 1.9 | |
| 71.9 | 8,997.9 | 12,669.0 | 407.0 | 5.4 | 11.8 | 22.4 | 2.7 | |
| 168.1 | 8,955.9 | 1,973.6 | -494.5 | -11.4 | -41 | -- | 9.5 | |
| 254.5 | 9,947.5 | 1,240.1 | 42.2 | 4.1 | 3.6 | 237.8 | 8.2 | |
| 120.1 | 6,677.4 | 645.7 | -25.4 | 6.8 | -1.3 | -- | 3.4 |
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company... offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; and Cleared which provides personalized treatments for allergy, asthma and immunology. It also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. Further, it offers GLP-1 for weight management and in-home health monitoring devices. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York. Address: 236 Fifth Avenue, New York, NY, United States, 10001 Read more
Chairman & CEO
Mr. Justin Schreiber
Chairman & CEO
Mr. Justin Schreiber
Headquarters
New York, NY
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of LifeMD Inc (LFMD) stood at $ 135 Mln as on 31-Mar-25
The share price of LifeMD Inc (LFMD) is $14.30 (NASDAQ) as of 23-Jun-2025 16:14 EDT. LifeMD Inc (LFMD) has given a return of 85.78% in the last 3 years.
LifeMD Inc (LFMD) has a market capitalisation of $ 671 Mln as on 23-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of LifeMD Inc (LFMD) is 107.72 times as on 23-Jun-2025, a 2960% premium to its peers’ median range of 3.52 times.
Since, TTM earnings of LifeMD Inc (LFMD) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the LifeMD Inc (LFMD) and enter the required number of quantities and click on buy to purchase the shares of LifeMD Inc (LFMD).
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; and Cleared which provides personalized treatments for allergy, asthma and immunology. It also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. Further, it offers GLP-1 for weight management and in-home health monitoring devices. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York. Address: 236 Fifth Avenue, New York, NY, United States, 10001
The CEO & director of Mr. Justin Schreiber. is LifeMD Inc (LFMD), and CFO & Sr. VP is Mr. Justin Schreiber.
There is no promoter pledging in LifeMD Inc (LFMD).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
995
|
|
|
906
|
|
|
889
|
|
|
883
|
|
|
777
|
|
|
708
|
|
|
663
|
|
|
663
|
|
|
585
|
| LifeMD Inc. (LFMD) | Ratios |
|---|---|
|
Return on equity(%)
|
--
|
|
Operating margin(%)
|
-3.36
|
|
Net Margin(%)
|
-5.21
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of LifeMD Inc (LFMD) was $0 Mln.
$-0.46
(
